Clorox’s stock (NYSE: CLX) has declined 19% year-to-date, significantly underperforming the consumer staples sector, which has gained nearly 5%. The company’s quarterly results missed Wall Street expectations, and it lowered its full-year fiscal guidance due to macroeconomic factors, including tariffs and a costly transition to a new enterprise resource planning (ERP) system.
Despite these challenges, Clorox has reported ten consecutive quarters of gross margin expansion and projects earnings of $5.73 to $6.13 per share for fiscal 2025. The company has a dividend yield of 3.7%, outperforming the broader consumer staples sector’s yield of 2.4%. As of June, analysts are cautiously optimistic about Clorox’s long-term growth potential due to improved internal processes and divestments.
